RecruitingNCT03025074

Blood Collection Biorepository for Liver Disease Research

Virology, Immunology and Mechanisms of Liver Disease in Patients With Hepatitis C and Other Liver Diseases

Sponsor

State University of New York at Buffalo

Enrollment

1,000 participants

Start Date

Jul 1, 2013

Study Type

OBSERVATIONAL

Conditions

Cirrhosis Fibrosis Hepatitis B Hepatitis C Fatty Liver Bariatric Surgery Candidate Obesity, Childhood Non-Alcoholic Steatohepatitis(NASH)

Summary

The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.

Eligibility

Min Age: 7 Years

Plain Language Summary

Simplified for easier understanding

This study creates a collection (biobank) of blood samples from people with and without liver disease — including viral hepatitis, liver cancer, and fatty liver disease — to help researchers better understand and treat these conditions. **You may be eligible if...** - You have a liver disease such as hepatitis B or C, liver cancer, or fatty liver disease (NASH), OR you are a healthy person with no liver disease who can serve as a comparison (control) - Children and teenagers may also participate **You may NOT be eligible if...** - You are an adult who cannot give informed consent on your own - You are an infant - You are pregnant - You are a prisoner Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.